SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: 2013 Report on the European Injectable Drug Delivery Market

[December 12, 2013]

Research and Markets: 2013 Report on the European Injectable Drug Delivery Market

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/97szxx/european) has announced the addition of the "2013 Report on the European Injectable Drug Delivery Market " report to their offering.

Germany accounted for the largest market share of the European injectable drug delivery technologies market in 2012, followed by France. While Germany is a mature market experiencing a surge in biologics and high incidence of chronic diseases, France is the fastest-growing region. This is due to high insurance coverage for injectable devices and formulations, affordability for healthcare expenses, and activities such as exhibitions and conferences hosted by France that address injectable drug delivery technologies.

The other European regions of Spain, Italy and Russia show high export potential for plastic syringes and needle, rising support for generics market, and increasing expenditure in the healthcare sector. The regions of Switzrland, Denmark, Ireland, Greece, Hungary, the Netherlands, Poland, Portugal, Romania, and Ukraine provide benefits such as favorable environment for research and development, growth in diabetic expenditures, and favorable reimbursement policies for injectable devices.


Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 European Injectable Drug Delivery Devices Technologies Market

4.1 Introduction

4.2 Market Segmentation

4.3 Manufacturers Criteria For Selection Of An Injectable Device

4.4 Conventional Injectable Drug Delvery Devices

4.5 Self-Injection Devices

4.6 Others

5 European Injectable Drug Delivery Formulation Technologies Market

6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications

6.1 Introduction

6.2 Auto-Immune Diseases

6.3 Hormonal Disorders

6.4 Orphan/Rare Diseases

6.5 Oncology

6.6 Others

7 Geographic Analysis

7.1 Introduction

7.2 Germany

7.3 France

7.4 U.K.

7.5 Spain

7.6 Italy

7.7 Russia

7.8 Rest Of Europe

8 Competitive Landscape

8.1 Introduction

8.2 Expansion

8.3 Agreements, Partnerships, Collaborations & Joint Ventures

8.4 New Product Launch

8.5 Mergers & Acquisitions

8.6 Other Developments

9 Company Profiles

Companies Mentioned:

  • Alkermes
  • Bespak Europe
  • Crossject
  • Gerresheimer
  • Haselmeier
  • Injex Pharma
  • Novo Nordisk
  • Owen Mumford
  • Sanofi
  • Schott
  • Vetter Pharma-Fertigung Gmbh & Co
  • Ypsomed Holding

For more information visit http://www.researchandmarkets.com/research/97szxx/european


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.